These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23438696)

  • 1. Negative dimension in psychiatry. Amotivational syndrome as a paradigm of negative symptoms in substance abuse.
    Rovai L; Maremmani AG; Pacini M; Pani PP; Rugani F; Lamanna F; Schiavi E; Mautone S; Dell'Osso L; Maremmani I
    Riv Psichiatr; 2013; 48(1):1-9. PubMed ID: 23438696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Amotivational syndrome of chronic organic solvent abusers--neuropsychological study].
    Fukui K; Kobayashi T; Hayakawa S; Koga E; Ono I; Kawakami F; Fukui Y; Tani N; Kato A; Nakajima T
    Arukoru Kenkyuto Yakubutsu Ison; 1995 Oct; 30(5):367-74. PubMed ID: 8534224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of amotivational syndrome as a residual symptom after methamphetamine abuse].
    Ashizawa T; Saito T; Yamamoto M; Shichinohe S; Ishikawa H; Maeda H; Toki S; Ozawa H; Watanabe M; Takahata N
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 1996 Oct; 31(5):451-61. PubMed ID: 8940805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral interventions for dual-diagnosis patients.
    Goldsmith RJ; Garlapati V
    Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amotivational syndrome in organic solvent abusers].
    Ozaki S; Wada K
    Nihon Yakurigaku Zasshi; 2001 Jan; 117(1):42-8. PubMed ID: 11233295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers.
    Camacho A; Akiskal HS
    J Affect Disord; 2005 Mar; 85(1-2):217-30. PubMed ID: 15780692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.
    Potvin S; Stip E; Lipp O; Elie R; Mancini-Marië A; Demers MF; Roy MA; Bouchard RH; Gendron A
    Curr Med Res Opin; 2006 Jul; 22(7):1277-85. PubMed ID: 16834826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhalant abusers and psychiatric symptoms].
    Okudaira K; Yabana T; Takahashi H; Iizuka H; Nakajima K; Saito A
    Seishin Shinkeigaku Zasshi; 1996; 98(4):203-12. PubMed ID: 8710994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurobiological mechanisms in addictive and psychiatric disorders.
    Bruijnzeel AW; Repetto M; Gold MS
    Psychiatr Clin North Am; 2004 Dec; 27(4):661-74. PubMed ID: 15550286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Related, induced and associated psychiatric disorders to cannabis].
    Laqueille X
    Rev Prat; 2005 Jan; 55(1):30-4. PubMed ID: 15801394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heavy cannabis users seeking treatment- prevalence of psychiatric disorders.
    Arendt M; Munk-Jørgensen P
    Soc Psychiatry Psychiatr Epidemiol; 2004 Feb; 39(2):97-105. PubMed ID: 15052390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatric aspects of cannabis use in adolescents and young adults.
    Tunving K
    Pediatrician; 1987; 14(1-2):83-91. PubMed ID: 3497393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychiatric emergencies in drug addiction].
    Benyamina A; Bouchez J; Rahioui H; Reynaud M
    Rev Prat; 2003 Jun; 53(11):1201-8. PubMed ID: 15185645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [So called "soft" drugs: cannabis and the amotivational syndrome].
    Schmits E; Quertemont E
    Rev Med Liege; 2013; 68(5-6):281-6. PubMed ID: 23888577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Children of substance abusers: overview of research findings.
    Johnson JL; Leff M
    Pediatrics; 1999 May; 103(5 Pt 2):1085-99. PubMed ID: 10224196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking cessation efforts among substance abusers with and without psychiatric comorbidity.
    Unrod M; Cook T; Myers MG; Brown SA
    Addict Behav; 2004 Jul; 29(5):1009-13. PubMed ID: 15219350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.